<!DOCTYPE html><html><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no"/><meta http-equiv="X-UA-Compatible" content="IE=edge"/><link rel="shortcut icon" href="/static/favicon.png" type="image/x-icon"/><meta property="og:title" content="Synx"/><link rel="stylesheet" type="text/css" charset="UTF-8" href="https://cdnjs.cloudflare.com/ajax/libs/slick-carousel/1.6.0/slick.min.css"/><link rel="stylesheet" type="text/css" href="https://cdnjs.cloudflare.com/ajax/libs/slick-carousel/1.6.0/slick-theme.min.css"/><base href="/"/><meta charSet="utf-8" class="next-head"/><link rel="icon" href="/static/favicon.png" class="jsx-827469350 next-head"/><title class="jsx-458499360 next-head">Synx - Impact on Healthcare.</title><link rel="preload" href="/_next/static/pwIxidqb5h~7cqKHq~vYE/pages/diabetic-retinopathy.js" as="script"/><link rel="preload" href="/_next/static/pwIxidqb5h~7cqKHq~vYE/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-838b392324e3598684b5.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.f72586d961ac67dc5f67.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-8469a754455bbd010c63.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.5502dec0.chunk.css"/><style id="__jsx-827469350">@font-face{font-family:"Neufile Grotesk";font-weight:400;src:url("/static/fonts/NeufileGrotesk-Regular.ttf") format("truetype");}@font-face{font-family:"Neufile Grotesk";font-weight:700;src:url("/static/fonts/NeufileGrotesk-Bold.ttf") format("truetype");}::selection{background:#ffb7b7;}body{background:rgb(26,26,26);color:#d9d8d6;font-size:24px;line-height:1.4166666667;font-family:"Neufile Grotesk";font-weight:400;}body>div{width:100vw;overflow-x:hidden;}h1{color:#ffffff;font-weight:700;font-size:110px;line-height:1.2727272727;}h2{color:#ffffff;font-weight:700;font-size:80px;line-height:1.75;}h3{color:#ffffff;font-weight:700;font-size:24px;padding-bottom:12px;}h3::before{content:"";position:relative;display:inline-block;height:24px;width:24px;background:url(/static/arrow.svg);background-repeat:no-repeat;background-position:center;top:2px;}.synx-slogan{color:#fff;margin:6rem 0 7rem;font-size:60px;line-height:1.3333333333;font-weight:700;}.flex-1{-webkit-flex:1;-ms-flex:1;flex:1;}.synx-line{margin-top:-2rem;margin-bottom:-2rem;width:250vw;display:block;-webkit-filter:hue-rotate(0deg);filter:hue-rotate(0deg);}.subheader-content{padding:5rem 0;}.synx-case-study{position:relative;margin-bottom:3rem;}.-invert.synx-case-study{padding-top:3rem;}.synx-image-hue{background:url("/static/assets/synx-hue.svg");background-size:cover;display:inline-block;width:50%;}.synx-image-hue>div{top:-2px;left:-2px;}.synx-small-link{color:#686868;font-size:18px;margin-top:2rem;display:block;font-weight:400;border-bottom:1px solid #686868;display:inline-block;-webkit-text-decoration:none;text-decoration:none;}.synx-small-link:hover{color:#fff;border-bottom:1px solid #fff;}.synx-email{background:rgba(0,0,0,0.45);padding:2rem 0;text-align:center;}.synx-email h2{color:rgba(255,255,255,0.7);}table{margin:3rem 0;width:100%;border-collapse:collapse;}thead{background:#222;}td,th{border-collapse:collapse;padding:0.618rem 1rem;line-height:1;border:1px solid #666;}.synx-table-header{font-style:italic;text-align:center;margin:2rem 0 -2rem;}@media screen and (max-width:1000px){body{font-size:16px;}h1{font-size:54px;}h2{font-size:32px;}h3{font-size:18px;}.subheader-content{padding:3rem 0;}.synx-slogan{font-size:32px;}.synx-line{margin-top:-1rem;margin-bottom:2rem;max-width:150vw;width:150vw;}}</style><style id="__jsx-458499360">.small{font-size:0.95rem;padding:0.3rem 0;}.study-illustration{margin:3rem auto;max-width:640px;}</style><style id="__jsx-586832693">.topnav{width:100%;display:block;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;z-index:10;position:fixed;top:0;left:0;}.topnav-content{background:rgb(26,26,26);}.topnav-header{height:8rem;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}.topnav-logo{cursor:pointer;padding:absolute;top:0;left:0;height:44px;}.topnav-menu{height:8rem;line-height:8rem;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}.topnav-menu img{height:12px;padding-left:0.618rem;}.topnav-link{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;-webkit-user-select:none;color:#808080;-webkit-text-decoration:none;text-decoration:none;display:inline-block;padding:1rem;right:-1rem;cursor:pointer;}.topnav-link.-active{background:#000;color:#fff;}.topnav-link:hover{color:#fff;}.topnav-menu.-mobile{display:none;}.topnav-mobile-menu{height:0;-webkit-transition:height 0.3s;transition:height 0.3s;overflow:hidden;background:#fff;position:fixed;top:0;left:0;width:100vw;}.-open .topnav-mobile-menu{height:90vh;}.topnav-mobile-menu_big-link{-webkit-text-decoration:none;text-decoration:none;line-height:80px;display:block;font-size:34px;color:#444;font-weight:700;margin:0 1rem;padding:0 0.5rem;border-top:1px solid #b3b3b3;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;}.topnav-mobile-menu .topnav-header{margin:0 2rem;}.topnav-case-study_container_title{font-weight:700;font-size:18px;margin-left:1.5rem;color:#777;}.topnav-case-study{display:block;-webkit-text-decoration:none;text-decoration:none;margin:0 1rem;padding:1rem 0.5rem;border-top:1px solid #b3b3b3;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;}.topnav-case-study:first-of-type{border-top:none;}.topnav-case-study_title{font-weight:700;color:#444;font-size:18px;}.topnav-case-study_description{color:#808080;font-size:18px;}.topnav-desktop_case-study{background:#fff;position:absolute;top:100%;right:8rem;width:20rem;}@media screen and (max-width:767px){.topnav-logo{height:34px;}.topnav-header{height:6rem;}.topnav-menu{height:6rem;line-height:6rem;}.topnav-menu{display:none;}.topnav-menu.-mobile{display:block;}}</style><style id="__jsx-3020757400">.apiviewer-mini{border:0.25rem solid rgb(26,26,26);height:5.5rem;}.apiviewer-mini img{height:5rem;width:7.5rem;margin:0;padding:0;}.apiviewer-images-scroll{height:6.5rem;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.apiviewer-mini.-active{border:0.25rem solid #c6d5ff;}.apiviewer{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;}.apiviewer-selector{display:inline-block;-webkit-flex:1;-ms-flex:1;flex:1;width:50%;}.apiviewer-result{background:#333;-webkit-flex:1;-ms-flex:1;flex:1;width:50%;padding:1.5rem;font-size:1rem;overflow-x:scroll;}.apiviewer-images{overflow-x:scroll;overflow-y:hidden;-webkit-overflow-scrolling:touch;}@media screen and (max-width:767px){.apiviewer{display:block;}.apiviewer-selector{display:block;width:100%;}.apiviewer-result{width:100%;}}</style><style id="__jsx-1524807495">.footer{background-color:#000;padding:3rem 0 4rem;margin-top:3rem;font-size:16px;line-height:28/16;position:relative;}.synx-hue-line{height:3px;width:100vw;background-image:url("/static/assets/synx-hue.svg");background-position:bottom;background-size:cover;position:absolute;bottom:0;left:0;}.footer a{color:#b3b3b3;-webkit-text-decoration:none;text-decoration:none;display:block;padding:0.25rem 0;}.footer a:hover{color:#fff;}.footer-header{font-weight:700;color:#595959;margin-bottom:1rem;}.footer-logo{height:1.25rem;opacity:0.5;cursor:pointer;}.footer-logo:hover{opacity:1;}.footer-grid-content{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.footer-column{width:200px;}</style></head><body><div id="__next"><div class="jsx-458499360 grid"><div class="jsx-458499360 grid-content"><div class="jsx-458499360 grid-header"><div class="jsx-586832693 topnav "><div class="jsx-586832693 topnav-content grid-content"><div class="jsx-586832693 topnav-header"><img src="./static/synx-logo.svg" class="jsx-586832693 topnav-logo"/><div class="jsx-586832693 flex-1"></div><div class="jsx-586832693 topnav-menu -mobile"><a class="jsx-586832693">Menu<img src="./static/assets/icon-hamburguer.svg" class="jsx-586832693"/></a></div><div class="jsx-586832693 topnav-menu"><a class="jsx-586832693 topnav-link ">Case Studies</a><a class="jsx-586832693 topnav-link" href="/about/">About</a><a class="jsx-586832693 topnav-link" href="/contact/">Contact</a></div></div></div><div class="jsx-586832693 topnav-mobile-menu"><div class="jsx-586832693 topnav-header"><img src="./static/synx-logo.svg" style="filter:invert(100%)" class="jsx-586832693 topnav-logo"/><div class="jsx-586832693 flex-1"></div><div class="jsx-586832693 topnav-menu -mobile"><a class="jsx-586832693">Menu<img src="./static/assets/icon-hamburguer.svg" class="jsx-586832693"/></a></div></div><div class="jsx-586832693 topnav-case-study_container_title">Case Studies</div><a class="jsx-586832693 topnav-case-study" href="/diabetic-retinopathy/"><div class="jsx-586832693 topnav-case-study_title">Impact on health care</div><div class="jsx-586832693 topnav-case-study_description">Our data exploration toolkit enables people to interact and analyze data in a more efficient way.</div></a><a class="jsx-586832693 topnav-case-study" href="/emotion-recognition/"><div class="jsx-586832693 topnav-case-study_title">Emotions Recognition.</div><div class="jsx-586832693 topnav-case-study_description">From people’s emotions based on their face expressions to complex biometrics and identification.</div></a><a class="jsx-586832693 topnav-mobile-menu_big-link" href="/about/">About</a><a class="jsx-586832693 topnav-mobile-menu_big-link" href="/contact/">Contact</a></div></div><section class="jsx-458499360 subheader-content"><h1 class="jsx-458499360">Impact on Healthcare.</h1>A case on Diabetic Retinopathy.</section></div></div><div class="jsx-458499360 grid-content">By applying Deep Learning and Computer Vision, we can achieve faster diagnostics, which leads to the optimization of the way patients are treated in the whole process and the decision making from the doctor.<h2 class="jsx-458499360">Abstract</h2>We developed an automatic screening/diagnostic system for diabetic retinopathy using an ensemble of deep neural networks followed by a random forest classifier. Our system has a sensitivity of 95% and a specificity of 65%.<br class="jsx-458499360"/><br class="jsx-458499360"/><div class="jsx-3020757400 apiviewer"><div class="jsx-3020757400 apiviewer-selector"><img src="./static/assets/diabetic-retinopathy/10004_left.jpg" class="jsx-3020757400"/><div class="jsx-3020757400 apiviewer-images"><div style="width:80rem" class="jsx-3020757400 apiviewer-images-scroll"><div class="jsx-3020757400 apiviewer-mini -active"><img src="./static/assets/diabetic-retinopathy/10004_left.jpg" class="jsx-3020757400"/></div><div class="jsx-3020757400 apiviewer-mini "><img src="./static/assets/diabetic-retinopathy/10062_left.jpg" class="jsx-3020757400"/></div><div class="jsx-3020757400 apiviewer-mini "><img src="./static/assets/diabetic-retinopathy/10125_right.jpg" class="jsx-3020757400"/></div><div class="jsx-3020757400 apiviewer-mini "><img src="./static/assets/diabetic-retinopathy/10219_left.jpg" class="jsx-3020757400"/></div><div class="jsx-3020757400 apiviewer-mini "><img src="./static/assets/diabetic-retinopathy/10236_right.jpg" class="jsx-3020757400"/></div><div class="jsx-3020757400 apiviewer-mini "><img src="./static/assets/diabetic-retinopathy/10376_left.jpg" class="jsx-3020757400"/></div><div class="jsx-3020757400 apiviewer-mini "><img src="./static/assets/diabetic-retinopathy/10378_right.jpg" class="jsx-3020757400"/></div><div class="jsx-3020757400 apiviewer-mini "><img src="./static/assets/diabetic-retinopathy/10446_right.jpg" class="jsx-3020757400"/></div><div class="jsx-3020757400 apiviewer-mini "><img src="./static/assets/diabetic-retinopathy/10551_right.jpg" class="jsx-3020757400"/></div><div class="jsx-3020757400 apiviewer-mini "><img src="./static/assets/diabetic-retinopathy/1071_right.jpg" class="jsx-3020757400"/></div></div></div></div><div class="jsx-3020757400 apiviewer-result">// Example API Response<br class="jsx-3020757400"/><br class="jsx-3020757400"/><pre class="jsx-3020757400">{
  &quot;label&quot;: &quot;No DR&quot;,
  &quot;sum_r&quot;: 0.000285714285714285,
  &quot;sum_y&quot;: 0.018857143,
  &quot;red_alert&quot;: false,
  &quot;yellow_alert&quot;: false,
  &quot;probs&quot;: {
    &quot;healthy&quot;: 0.908857143,
    &quot;mild&quot;: 0.0722857143,
    &quot;moderate&quot;: 0.0185714286,
    &quot;severe&quot;: 0.000285714286,
    &quot;proliferative&quot;: 0
  }
}</pre></div></div><br class="jsx-458499360"/><h3 class="jsx-458499360">Problem overview</h3>Diabetic retinopathy (DR), a major microvascular complication of diabetes, has a significant impact on the world&#x27;s health systems. In Mexico alone this disease affects more than 11 million people [1]. Globally, the number of people with DR will grow from 126.6 million in 2010 to 191.0 million by 2030, and it is estimated that the number with vision-threatening diabetic retinopathy (VTDR) will increase from 37.3 million to 56.3 million, if prompt action is not taken.<br class="jsx-458499360"/><br class="jsx-458499360"/>Despite growing evidence documenting the effectiveness of routine DR screening and early treatment, DR frequently leads to poor visual functioning and represents the leading cause of blindness in working-age populations. DR has been neglected in health-care research and planning in many low-income countries, where access to trained eye-care professionals and tertiary eye-care services may be inadequate. Demand for, as well as, supply of services may be a problem. Rates of compliance with diabetes medications and annual eye examinations may be low, the reasons for which are multifactorial [2].<br class="jsx-458499360"/><br class="jsx-458499360"/><h3 class="jsx-458499360">Motivation</h3>With the intention of developing an automatic diagnostic system for the screening of patients with possible diabetic retinopathy, we used recent advances in computer vision and deep learning to train an ensamble of neural networks to detect this disease and its level of progression.<br class="jsx-458499360"/><br class="jsx-458499360"/><br class="jsx-458499360"/><h2 class="jsx-458499360">Model overview</h2><h3 class="jsx-458499360">Data</h3>For training and validation, we used 85,000 high-resolution images, each one consisting of a digital slit lamp capture, labeled with the proper diagnosis (made by a clinician who rated the severity of the disease). Each image is labeled as being [0] no DR, [1] mild DR, [2] moderate DR, [3] severe DR or [4] proliferative DR. The per-class representation in the dataset is as follows:<table class="jsx-458499360"><thead class="jsx-458499360"><tr class="jsx-458499360"><th class="jsx-458499360">Class</th><th class="jsx-458499360">Number of images</th></tr></thead><tbody class="jsx-458499360"><tr class="jsx-458499360"><td class="jsx-458499360">No DR</td><td class="jsx-458499360">62,920</td></tr><tr class="jsx-458499360"><td class="jsx-458499360">Mild DR</td><td class="jsx-458499360">5,650</td></tr><tr class="jsx-458499360"><td class="jsx-458499360">Moderate DR</td><td class="jsx-458499360">12,440</td></tr><tr class="jsx-458499360"><td class="jsx-458499360">Severe DR</td><td class="jsx-458499360">2,020</td></tr><tr class="jsx-458499360"><td class="jsx-458499360">Proliferative DR</td><td class="jsx-458499360">1,690</td></tr></tbody></table>The data was randomly divided between train (90%) and test (10%) sets. Test results were used for early-stopping during training and to choose some metaparameters of the neural networks. An example image from original data. An example image from original data.<br class="jsx-458499360"/><br class="jsx-458499360"/><div class="jsx-458499360 study-illustration"><div class="ratio-image fixed-aspect-image " style="background-size:cover;background-position:center;display:flex;max-width:100%;height:0;background-image:url(./static/assets/diabetic-retinopathy/normal.jpg);padding:0 0 100%"></div></div><h3 class="jsx-458499360">Preprocessing</h3>The eye is detected and the image is rescaled and adjusted so that the eye is always in the center with a fixed size. RGB channels are locally normalized with a moving gaussian kernel in order to highlight local image variability. This allows the model to be agnostic to global light intensity and other factors depending on the particular camera used.<div class="jsx-458499360 study-illustration"><div class="ratio-image fixed-aspect-image " style="background-size:cover;background-position:center;display:flex;max-width:100%;height:0;background-image:url(./static/assets/diabetic-retinopathy/preprocessed.jpg);padding:0 0 100%"></div></div>An example image from original data. This image represent the final image from a Proliferative DR study used for neural network training.<br class="jsx-458499360"/><br class="jsx-458499360"/><h3 class="jsx-458499360">Neural Networks</h3>Several neural networks were trained using different architectures (InceptionV3, Resnet50). The training leveraged transfer learning from an Imagenet model, and was done in stages from the top-most layers gradually diminishing the learning rate. Two weeks of 2-gpu servers were used for the training of each model.<div class="jsx-458499360 study-illustration"><div class="ratio-image fixed-aspect-image " style="background-size:cover;background-position:center;display:flex;max-width:100%;height:0;background-image:url(./static/assets/diabetic-retinopathy/heatmap.jpg);padding:0 0 100%"></div></div>An example image from original data. After training, a neural network is capable to evaluate preprecessed images, this image shows the heatmap where damage is being found on a Proliferative DR patient.<br class="jsx-458499360"/><br class="jsx-458499360"/><h3 class="jsx-458499360">Random Forest</h3>We trained a Random Forest to combine the results of the different neural networks on both eyes of the patient with other statistics from the images, to predict the final probabilities that a particular image corresponds to a certain level of DR. This stage assigns to each image a vector with the probabilities of each class.<br class="jsx-458499360"/><br class="jsx-458499360"/><h3 class="jsx-458499360">Label aggregation</h3>Most guidelines recommend annual screening for those with no Retinopathy or mild Diabetic Retinopathy; every 6 months for moderate Diabetic Retinopathy, and an Ophthalmologist referral for treatment evaluation within a few weeks or months for severe or proliferative Diabetic retinopathy [3].<br class="jsx-458499360"/><br class="jsx-458499360"/>Following other studies such as [3], we define a negative case as no-DR or mild-DR, and a positive case as moderate, severe or proliferative DR. The vector of probabilities is therefore simplified into the probability of being a positive DR case. We can now create a ROC curve to choose the threshold for our prediction. A family of models with different sensibility and specificity. In figure X we can see the different possibilities. Among these we chose a model with 95% sensitivity and a corresponding 65% specificity so that it serves as a good first screening layer in a diagnostic pipeline.<br class="jsx-458499360"/><br class="jsx-458499360"/>In a similar fashion, we created a Red alert using only severe and proliferative DR as positive cases and looking for a sensitivity of 0.9. These two alerts, yellow and red have the following statistics:<div class="synx-table-header" class="jsx-458499360">Table 1</div><table class="jsx-458499360"><thead class="jsx-458499360"><tr class="jsx-458499360"><th class="jsx-458499360">Class</th><th class="jsx-458499360">Yellow alert</th><th class="jsx-458499360">Red alert</th></tr></thead><tbody class="jsx-458499360"><tr class="jsx-458499360"><td class="jsx-458499360">No DR</td><td class="jsx-458499360">18%</td><td class="jsx-458499360">1%</td></tr><tr class="jsx-458499360"><td class="jsx-458499360">Mild DR</td><td class="jsx-458499360">57%</td><td class="jsx-458499360">2%</td></tr><tr class="jsx-458499360"><td class="jsx-458499360">Moderate DR</td><td class="jsx-458499360">90%</td><td class="jsx-458499360">38%</td></tr><tr class="jsx-458499360"><td class="jsx-458499360">Severe DR</td><td class="jsx-458499360">98%</td><td class="jsx-458499360">89%</td></tr><tr class="jsx-458499360"><td class="jsx-458499360">Proliferative DR</td><td class="jsx-458499360">98%</td><td class="jsx-458499360">91%</td></tr><tr class="jsx-458499360"><td class="jsx-458499360">No DR or Mild DR</td><td class="jsx-458499360"><b class="jsx-458499360">35%</b> <div class="jsx-458499360 small">(general specificity = 65%)</div></td><td class="jsx-458499360">1%</td></tr><tr class="jsx-458499360"><td class="jsx-458499360">Moderate, Severe or Proliferative</td><td class="jsx-458499360"><b class="jsx-458499360">95%</b> <div class="jsx-458499360 small">(general sensivity)</div></td><td class="jsx-458499360">50%</td></tr><tr class="jsx-458499360"><td class="jsx-458499360">Severe or Proliferative</td><td class="jsx-458499360">98%</td><td class="jsx-458499360">90%</td></tr></tbody></table><br class="jsx-458499360"/>The probability of triggering the Yellow or Red alerts when the patient has a certain class level of Retinopathy. We see that the Red alert is only likely to be triggered with Moderate, Severe or Proliferative DR; while Yellow alert is more conservative and is able to detect 95% of all positive cases. In combination, both alerts can be extremely useful for the early detection of diabetic retinopathy.<br class="jsx-458499360"/><br class="jsx-458499360"/><h3 class="jsx-458499360">Further steps for improving the model’s performance:</h3><ul class="jsx-458499360"><li class="jsx-458499360">A more robust labeling following the example of [3] would definitely decrease the prediction error. In order to do this we will collaborate with a team of Ophthalmologists for systematic robust diagnosis and localization of wounds.</li><li class="jsx-458499360">During the Random Forest stage, the inclusion of additional addition of certain data from the patients (such as glucose levels, age, etc) would be very valuable.</li><li class="jsx-458499360">Currently, the model uses an ensemble of 3 neural networks. If we were to use at least 10, we could increase the accuracy of the model. In addition, working with larger (higher resolution) images could allow us to detect smaller wounds. Both neural network increased ensemble, and higher resolution images, imply more power during training.</li></ul></div><div class="jsx-1524807495 footer"><div class="jsx-1524807495 footer-grid-content grid-content"><section class="jsx-1524807495 footer-column"><div class="jsx-1524807495 footer-header"><img src="./static/synx-logo.svg" class="jsx-1524807495 footer-logo"/></div></section><section class="jsx-1524807495 footer-column"><div class="jsx-1524807495 footer-header">Company</div><a class="jsx-1524807495 footer-link" href="/about/">About</a><a class="jsx-1524807495 footer-link" href="/contact/">Contact</a></section></div><div style="filter:hue-rotate(0deg)" class="jsx-1524807495 synx-hue-line"></div></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{}},"page":"/diabetic-retinopathy","query":{},"buildId":"pwIxidqb5h~7cqKHq~vYE","nextExport":true}</script><script async="" id="__NEXT_PAGE__/diabetic-retinopathy" src="/_next/static/pwIxidqb5h~7cqKHq~vYE/pages/diabetic-retinopathy.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/pwIxidqb5h~7cqKHq~vYE/pages/_app.js"></script><script src="/_next/static/runtime/webpack-838b392324e3598684b5.js" async=""></script><script src="/_next/static/chunks/commons.f72586d961ac67dc5f67.js" async=""></script><script src="/_next/static/runtime/main-8469a754455bbd010c63.js" async=""></script></body></html>